Back to matchesWe found a matchYour institution may have rights to this item. Sign in to continue.TitlePORTIA: A PHASE 1B STUDY EVALUATING SAFETY AND EFFICACY OF TISAGENLECLEUCEL AND PEMBROLIZUMAB IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA.AuthorsJaeger, U.; McGuirk, J.; Worel, N.; Riedell, P.; Fleury, I.; Borchmann, P.; Forcina, A.; Chu, J.; Leung, M.; Pacaud, L.; Waller, E.SubjectsDIFFUSE large B-cell lymphomas; PEMBROLIZUMABPublicationHematological Oncology, 2019, Vol 37, p560ISSN0278-0232Publication typeArticleDOI10.1002/hon.7_2632